STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Agios (Nasdaq: AGIO) will report its third quarter 2025 financial results and business highlights on Thursday, October 30, 2025 at 8:00 a.m. ET.

The company will host a conference call and live webcast accessible from the Investors > Events & Presentations section of its website. A replay will be available on the company website approximately two hours after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

CAMBRIDGE, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced the company will host a conference call and live webcast on Thursday, October 30, 2025, at 8:00 a.m. ET to report its third quarter 2025 financial results and business highlights.

The live webcast will be accessible on the Investors section of the company’s website (www.agios.com) under the “Events & Presentations” tab. A replay of the webcast will be available on the company’s website approximately two hours after the event.

About Agios: Fueled by Connections to Transform Rare Diseases™
At Agios, our vision is to redefine the future of rare disease treatment. Fueled by connections, we build trusted partnerships with communities – collaborating to develop and deliver innovative medicines that have the potential to transform lives. With a foundation in hematology, we combine biological expertise with real-world insights to advance a growing pipeline of rare disease medicines that reflect the priorities of the people we serve. Agios is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. To learn more, visit www.agios.com and follow us on LinkedIn and X.

Contacts:
Investor Contact
Morgan Sanford, Vice President, Investor Relations
Agios Pharmaceuticals
morgan.sanford@agios.com

Media Contact
Eamonn Nolan, Senior Director, Corporate Communications
Agios Pharmaceuticals
eamonn.nolan@agios.com


FAQ

When will Agios (AGIO) report Q3 2025 results?

Agios will report Q3 2025 results on October 30, 2025 with a call at 8:00 a.m. ET.

How can investors join the Agios (AGIO) Q3 2025 earnings webcast?

Join the live webcast via the Investors > Events & Presentations page on the Agios website.

Will there be a replay of the Agios (AGIO) October 30, 2025 webcast?

Yes. A replay will be available on the company website approximately two hours after the event.

What time is the Agios (AGIO) conference call for third quarter 2025?

The conference call is scheduled for 8:00 a.m. ET on October 30, 2025.

Where on the Agios website is the Q3 2025 event posted?

The event will be posted under Investors > Events & Presentations on agios.com.

Will Agios (AGIO) provide quarterly business highlights during the October 30, 2025 call?

Yes. The company will report third quarter 2025 financial results and business highlights during the call.
Agios Pharmaceuticals Inc

NASDAQ:AGIO

AGIO Rankings

AGIO Latest News

AGIO Latest SEC Filings

AGIO Stock Data

1.62B
55.92M
1.68%
112.91%
8.2%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE